Winner Profile
Xingtian Ma
CEO, Kangmei Pharmaceutical
Industry: Pharmaceuticals
Company size: Medium
Published: 2017-12-08
Is Kangmei Pharmaceutical a good stock investment?
Based on the annual Obermatt CEO of the Year analysis, Xingtian Ma (Kangmei Pharmaceutical) earned the following Obermatt pins for the management performance.
Obermatt accolades Xingtian Ma
| Year | Pin | Category |
|---|---|---|
| 2017 |  |
Investment Performance |
|
Combined Performance | |
 |
Growth Performance | |
|
Operating Performance |
Xingtian Ma was included in the competition among China 100 Ranking (China) (current winners). See the winners of the other competitions or how the CEOs performed over all competitions.
Performance Overview Xingtian Ma
In summary, Xingtian Ma obtained the following achievements in the individual Obermatt categories by participating in the Obermatt rankings (averages of all evaluated rankings are shown for this CEO, also for other companies):
CEO performance is displayed relative to that of other CEOs that competed in the same categories for the same number of competitions. A ranking of 79 in Combined Performance indicates that Xingtian Ma was better than 79% of all other CEOs that were analyzed as part of the China 100 Ranking – China for one participation in Obermatt CEO competitions. Xingtian Ma’s average ranking can be found in the Multi-Year Rankings for China 100 Ranking - China.